Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP204209.RAYxKErsrQNxl2d0o9x5mTbjGF3pXOv0bNNMXjHEYVbfI130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204209.RAYxKErsrQNxl2d0o9x5mTbjGF3pXOv0bNNMXjHEYVbfI130_provenance.
• NP744635.RAWjrLQQH90zKuNDuQMI8xNXlJcHIXRRFz69uFb3pFTUU130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744635.RAWjrLQQH90zKuNDuQMI8xNXlJcHIXRRFz69uFb3pFTUU130_provenance.
• NP406663.RAzBE9ecTA-1tnn-sou8sdNi70ggIc8sbfwTkoSONI6sw130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406663.RAzBE9ecTA-1tnn-sou8sdNi70ggIc8sbfwTkoSONI6sw130_provenance.
• NP680048.RA1yGdwBwAyuAmMlN1DOwipe7ymVGnA_zardgThWZLALI130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680048.RA1yGdwBwAyuAmMlN1DOwipe7ymVGnA_zardgThWZLALI130_provenance.
• NP1048939.RADhSUg4qswD-62jSqjor_1WX7ygHQbt0nDIBO-9zhTkc130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048939.RADhSUg4qswD-62jSqjor_1WX7ygHQbt0nDIBO-9zhTkc130_provenance.
• NP1048941.RAAH0xlqIQ1V9AWVrqKMBf8KR_hincVldNs_cgZ8GlpRc130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048941.RAAH0xlqIQ1V9AWVrqKMBf8KR_hincVldNs_cgZ8GlpRc130_provenance.
• NP304054.RA2erJi21fLyGRN2dzG8c96ASH-2az7FxPZBZjAfkmNpc130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304054.RA2erJi21fLyGRN2dzG8c96ASH-2az7FxPZBZjAfkmNpc130_provenance.
• NP860756.RAfBGALyMBKBqBGxpo-owtOxWbI0I4hbs-GpEUkNGMzxM130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860756.RAfBGALyMBKBqBGxpo-owtOxWbI0I4hbs-GpEUkNGMzxM130_provenance.
• NP860793.RAzEbI219AXAaKWFPJ1WalU5PesaBjjNN-xvvdtIs536A130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860793.RAzEbI219AXAaKWFPJ1WalU5PesaBjjNN-xvvdtIs536A130_provenance.
• NP860800.RA9dSYoAMSKsC5GvvUYDghO6bW6A3x3vRpyyql8OW7reY130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860800.RA9dSYoAMSKsC5GvvUYDghO6bW6A3x3vRpyyql8OW7reY130_provenance.
• NP1048938.RA4pjsDZdaXozf5UohrIV6ZzMBOCnC0wzeKWSEWc9t6P8130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048938.RA4pjsDZdaXozf5UohrIV6ZzMBOCnC0wzeKWSEWc9t6P8130_provenance.
• NP1048940.RA7gUCvXlohq9I0MUqOkAM-0bZH0f78-nFOmlYbNr3vuc130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048940.RA7gUCvXlohq9I0MUqOkAM-0bZH0f78-nFOmlYbNr3vuc130_provenance.
• NP304025.RALA9-uhbVRMV4z20q4oalCi1MZr7Y6EDMdLheGMqCyzc130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304025.RALA9-uhbVRMV4z20q4oalCi1MZr7Y6EDMdLheGMqCyzc130_provenance.
• NP1048935.RARh0rpl7Dv3RnPe2mugAyuQnvcwcboGQlaxr0YZIPZIU130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048935.RARh0rpl7Dv3RnPe2mugAyuQnvcwcboGQlaxr0YZIPZIU130_provenance.
• NP303887.RApi4eSwr-Kxu9mbD0OFfAyzFOPVqoMxPHUWw4MwSeeRk130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303887.RApi4eSwr-Kxu9mbD0OFfAyzFOPVqoMxPHUWw4MwSeeRk130_provenance.
• NP1048936.RAnbhmjN7bqyJ5sBdS7gZyWatd0MB2TNdKk4JiIMx4uao130_assertion description "[Recent studies have demonstrated the value of ancillary techniques, including p57 immunohistochemistry and short tandem repeat genotyping, for distinguishing hydatidiform moles (HM) from nonmolar specimens and for subtyping HMs as complete hydatidiform moles (CHM) and partial hydatidiform moles (PHM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048936.RAnbhmjN7bqyJ5sBdS7gZyWatd0MB2TNdKk4JiIMx4uao130_provenance.